90+ companies created
QUBIS
What is QUBIS?
Formed in 1984, QUBIS exists to help Queen’s University Belfast, turn high-quality academic inspiration into high-impact commercial innovation.
QUBIS works closely with talented academics, ambitious entrepreneurs, astute investors and a host of industry experts to form successful spin–off companies that combine cutting–edge research and development with market–focused products and services.
How can your organisation engage with QUBIS?
- Gain entrepreneurial expertise built into early-stage ventures
- Support with direct funds for your idea
- Step-by-step support to guide you through the journey of developing your company
- Enterprise programmes including Lean Launch Programme, EIT Food Seedbed and ICURe.
Over 2,700 employees
£100 million Total Capital Raised
Case studies
-
Kainos
Kainos has over 1,500 people across 13 offices in Europe and North America.
The Group’s Digital Services include full lifecycle development and support of customised Digital Services for government and commercial customers. Kainos is also the leading European partner for Workday, Inc. (‘Workday’), responsible for implementing Workday’s innovative Software–as–a–Service (SaaS) platform for enterprise and, now, government customers.
- Fusion Antibodies
Fusion Antibodies is dedicated to the discovery and early development of antibodies to help bring about a positive change in the healthcare industry.
Fusion Antibodies is a specialists in pre–clinical antibody discovery, engineering and supply for both therapeutic drug and diagnostic applications.
Established in 2001 as a spin–out from Queen’s University Belfast, Fusion Antibodies' mission is to enable drug discovery companies to develop innovative products in a timely and cost–effective manner for the benefit of the global healthcare industry.
The company has an international, blue–chip client base which includes 8 of the top 10 global pharmaceutical companies by revenue.
